Richard Matros - Sabra Health Pres Chairman

SBC Stock  EUR 17.49  0.10  0.58%   

Insider

Richard Matros is Pres Chairman of Sabra Health Care
Age 68
Phone772 287 4000
Webhttps://www.seacoastbanking.com

Richard Matros Latest Insider Activity

Tracking and analyzing the buying and selling activities of Richard Matros against Sabra Health stock is an integral part of due diligence when investing in Sabra Health. Richard Matros insider activity provides valuable insight into whether Sabra Health is net buyers or sellers over its current business cycle. Note, Sabra Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sabra Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Sabra Health Management Efficiency

The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0241) %, meaning that it generated substantial loss on money invested by shareholders. Sabra Health's management efficiency ratios could be used to measure how well Sabra Health manages its routine affairs as well as how well it operates its assets and liabilities.
Sabra Health Care has accumulated 2.31 B in total debt with debt to equity ratio (D/E) of 106.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sabra Health Care has a current ratio of 5.79, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Sabra Health until it has trouble settling it off, either with new capital or with free cash flow. So, Sabra Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sabra Health Care sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sabra to invest in growth at high rates of return. When we think about Sabra Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 6 records

INSIDER Age

Captain HughesGenco Shipping Trading
48
Peter CFAGenco Shipping Trading
N/A
Joseph AdamoGenco Shipping Trading
61
John WobensmithGenco Shipping Trading
53
Apostolos ZafoliasGenco Shipping Trading
44
Ivo KempenaerGenco Shipping Trading
N/A
As of March 31, 2019, Sabras investment portfolio included 437 real estate properties held for investment 304 Skilled NursingTransitional Care facilities, 88 Senior Housing communities , 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements and 22 Specialty Hospitals and Other facilities, 30 assets held for sale, one investment in a direct financing lease, 20 investments in loans receivable one mortgage loan, two construction loans and 17 other loans, nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing Managed communities. As of March 31, 2019, Sabras real estate properties held for investment included 43,884 bedsunits and its unconsolidated joint venture included 7,652 bedsunits, spread across the United States and Canada Sabra Health Care (SBC) is traded on Frankfurt Exchange in Germany and employs 42 people.

Management Performance

Sabra Health Care Leadership Team

Elected by the shareholders, the Sabra Health's board of directors comprises two types of representatives: Sabra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sabra. The board's role is to monitor Sabra Health's management team and ensure that shareholders' interests are well served. Sabra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sabra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Peter Nyland, Ex Management
Talya NevoHacohen, Chief VP
Michael Costa, CFO VP
Jeffrey Bray, Ex Ops
Darrin Smith, Ex Investments
Lukas CFA, VP Fin
Michael Sonego, Ex Exec
Joseph Forlenza, Ex Officer
Daniel Chappell, Chief VP
Charles Cross, Ex Pres
Juliette Kleffel, Ex Officer
Jeffery Lee, Ex Officer
Jennifer Reissman, Ex Officer
Tracey Dexter, Ex CFO
Eliza Gozar, VP Investments
Charles Shaffer, Pres Chairman
Harold Andrews, Consultant
Richard Matros, Pres Chairman

Sabra Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sabra Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Sabra Stock

Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.